Literature DB >> 17446547

Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy.

Ravi Murthy1, Daniel B Brown, Riad Salem, Steven G Meranze, Douglas M Coldwell, Sunil Krishnan, Rodolfo Nunez, Amit Habbu, David Liu, William Ross, Alan M Cohen, Michael Censullo.   

Abstract

Hepatic arterial therapy with yttrium-90 microspheres exploits the avenue provided by the neoplastic microvasculature to deliver high-energy, low-penetrating therapeutic doses of radiation. Variant hepatic arterial anatomy, collateral vessels, and changes in flow dynamics during treatment can affect particle dispersion and lead to nontarget particle distribution and subsequent gastrointestinal morbidity. Awareness of these variances and techniques to prevent gastrointestinal tract microsphere delivery is essential in mitigating this serious complication. Our aim is to increase the understanding of the role of various imaging and preventative techniques in minimizing this undesired effect.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17446547     DOI: 10.1016/j.jvir.2007.02.002

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  54 in total

Review 1.  Radioembolization for primary and metastatic liver cancer.

Authors:  Khairuddin Memon; Robert J Lewandowski; Laura Kulik; Ahsun Riaz; Mary F Mulcahy; Riad Salem
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

2.  Hepatic radioembolization complicated by gastrointestinal ulceration.

Authors:  Jeremy Collins; Riad Salem
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

Review 3.  A serious complication of selected internal radiation therapy: case report and literature review.

Authors:  Katrin M Sjoquist; David Goldstein; Lourens Bester
Journal:  Oncologist       Date:  2010-08-05

Review 4.  Chemoembolization and radioembolization for metastatic disease to the liver: available data and future studies.

Authors:  Khairuddin Memon; Robert J Lewandowski; Ahsun Riaz; Riad Salem
Journal:  Curr Treat Options Oncol       Date:  2012-09

5.  Is prophylactic embolization of the hepatic falciform artery needed before radioembolization in patients with 99mTc-MAA accumulation in the anterior abdominal wall?

Authors:  Hojjat Ahmadzadehfar; Markus Möhlenbruch; Amir Sabet; Carsten Meyer; Marianne Muckle; Torjan Haslerud; Kai Wilhelm; Hans Heinz Schild; Hans Jürgen Biersack; Samer Ezziddin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-15       Impact factor: 9.236

Review 6.  Skin Necrosis Resulting from Nontarget Embolization of the Falciform Artery during Transarterial Chemoembolization with Drug-Eluting Beads.

Authors:  Mitchell T Smith; David Thor Johnson; Matthew G Gipson
Journal:  Semin Intervent Radiol       Date:  2015-03       Impact factor: 1.513

Review 7.  Treatment response assessment following transarterial radioembolization for hepatocellular carcinoma.

Authors:  Zersenay Alem; Timothy E Murray; Csilla Egri; John Chung; David Liu; Khaled M Elsayes; Silvia D Chang; Alison Harris
Journal:  Abdom Radiol (NY)       Date:  2021-04-28

Review 8.  Advances in managing hepatocellular carcinoma.

Authors:  Marielle Reataza; David K Imagawa
Journal:  Front Med       Date:  2014-05-08       Impact factor: 4.592

9.  Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis.

Authors:  M A D Vente; M Wondergem; I van der Tweel; M A A J van den Bosch; B A Zonnenberg; M G E H Lam; A D van Het Schip; J F W Nijsen
Journal:  Eur Radiol       Date:  2008-11-07       Impact factor: 5.315

Review 10.  Update and review of the multidisciplinary management of stage IV colorectal cancer with liver metastases.

Authors:  Sherif Raafat Zikry Abdel-Misih; Carl R Schmidt; Paul Mark Bloomston
Journal:  World J Surg Oncol       Date:  2009-09-29       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.